切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (03) : 219 -223. doi: 10.3877/cma.j.issn.1674-3253.2022.03.006

临床研究

输尿管支架结痂的原因分析以及石痂与原发结石成分的比较
许悦贤1, 李国翔1, 郝宗耀1,()   
  1. 1. 230000 合肥,安徽医科大学第一附属医院泌尿外科;230000 合肥,安徽医科大学泌尿外科研究所;230000 合肥,安徽医科大学泌尿生殖系统疾病安徽省重点实验室
  • 收稿日期:2021-11-17 出版日期:2022-06-01
  • 通信作者: 郝宗耀
  • 基金资助:
    国家自然科学基金面上项目(82070724); 安徽省自然科学基金面上项目(1908085MH246)

Analysis the causes of ureteral stent encrustation and comparison of composition of encrustation and original stone

Yuexian Xu1, Guoxiang Li1, Zongyao Hao1,()   

  1. 1. Department of Urology, the First Affiliated Hospital of Anhui Medical University, Hefei 230000, China; Institute of Urology, Anhui Medical University, Hefei 230000, China; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230000, China
  • Received:2021-11-17 Published:2022-06-01
  • Corresponding author: Zongyao Hao
引用本文:

许悦贤, 李国翔, 郝宗耀. 输尿管支架结痂的原因分析以及石痂与原发结石成分的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(03): 219-223.

Yuexian Xu, Guoxiang Li, Zongyao Hao. Analysis the causes of ureteral stent encrustation and comparison of composition of encrustation and original stone[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(03): 219-223.

目的

探讨输尿管支架结痂的原因,比较石痂和原结石成分的异同,了解成因及预防。

方法

回顾性分析我院2020年3月至2021年8月80例输尿管支架结痂泌尿系结石患者,及同期接受治疗的80例输尿管支架未结痂泌尿系结石患者的资料。采用结石红外光谱自动分析系统分析结石及石痂,对比其成分的差异。

结果

结痂组与非结痂组患者的性别比例、年龄、肌酐、肾小球滤过率、肾积水情况、术前感染控制情况、尿培养情况、手术方式、结石部分、术后口服抗生素时间等差异均无统计学意义(P>0.05)。结痂组和非结痂组患者相比更容易出现腰痛(P<0.05)。结痂组和非结痂组患者相比患代谢综合征的比例高,结石清除率较低,尿pH值较高,饮食偏荤和喜饮茶者较多(P<0.05)。71.25%(57/80)患者的支架管石痂成分与原结石成分一致,28.75%(23/80)患者的支架管石痂与原发结石成分不一致,可能与感染控制不佳和代谢性疾病有关。

结论

输尿管支架结痂这一并发症需要引起足够的重视,大部分的石痂与原发结石成分相同。可通过改变生活习惯,控制带管时间,积极控制尿路感染及治疗代谢性疾病预防。

Objective

To investigate the causes and prevention of encrustation formation of ureteral stent and compare the encrustation and original stone components.

Methods

The data of 80 patients with urinary calculi in our hospital from March 2020 to August 2021 and their primary calculi and ureteral stents with encrustation were collected. The data of 80 patients with urinary calculi without encrustation on ureteral stent were statistically analyzed. The composition of stones and encrustations were analyzed using infrared spectroscopy analysis system.

Results

There was no significant difference in sex ratio, age, creatinine, glomerular filtration rate, hydronephrosis, preoperative infection control and postoperative oral antibiotic time between the two groups (P>0.05). The patients in encrustation group got more prone to low lumbago and hematuria (P<0.05). Compared with the non encrustation group, the patients in the encrustation group had higher incidence of metabolic syndrome, lower stone clearance rate, higher urinary pH, more meat eating and tea drinking (P<0.05). 71.25%(57/80) patients had the same encrustations composition as the original stone, 28.75%(23/80) patients had inconsistent stone composition, which may be related to poor infection control and metabolic diseases.

Conclusions

The complication of ureteral stent encrustation needs to be paid enough attention. Most of the encrustation are the same as the original stones. It can be prevented by changing living habits, controlling extubation time, actively controlling urinary tract infection and treating metabolic diseases.

表1 输尿管支架结痂组和未结痂组临床资料的比较
表2 结痂危险因素的OR值及95%CI
表3 支架石痂成分与原结石成分相同患者和不同患者资料的比较
[1]
Zhao J, Cao Z, Ren L, et al. A novel ureteral stent material with antibacterial and reducing encrustation properties[J]. Mater Sci Eng C Mater Biol Appl, 2016, 68: 221-228.
[2]
中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中国糖尿病杂志, 2004, 12(3): 156-161.
[3]
Hao P, Li W, Song C, et al. Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2 685 cases[J]. J Endourol, 2008, 22(1): 65-70.
[4]
El Faqih SR, Shamsuddin AB, Chakrabarti A, et al. Polyurethane internal stents in treatment of stone patients:morbidity related to indwelling times[J]. J Urol, 1991, 146(6): 1487-1491.
[5]
Kawahara T, Ito H, Terao H, et al. Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times[J]. J Endourol, 2012, 26(2):178-182.
[6]
Ather MH, Talati J, Biyabani R. Physician responsibility for removal of implants: the case for a computerized program for tracking overdue double-J stents[J]. Tech Urol, 2000, 6(3): 189-192.
[7]
Tenke P, Köves B, Nagy K, et al. Update on biofilm infections in the urinary tract[J]. World J Urol, 2012, 30(1): 51-57.
[8]
Tunney MM, Keane PF, Jones DS, et al. Comparative assessment of ureteral stent biomaterial encrustation[J]. Biomaterials, 1996, 17(15): 1541-1546.
[9]
Shabeena KS, Bhargava R, Manzoor MAP, et al. Characteristics of bacterial colonization after indwelling double-J ureteral stents for different time duration[J]. Urol Ann, 2018, 10(1): 71-75.
[10]
Szell T, Dressler FF, Goelz H, et al. In vitro effects of a novel coating agent on bacterial biofilm development on ureteral stents[J]. J Endourol, 2019, 33(3): 225-231.
[11]
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. PLoS Med, 2009, 6(7): e1000097.
[12]
Minardi D, Montanari MP, Tili E, et al. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents[J]. J Chemother, 2008, 20(2): 195-201.
[13]
Torrecilla C, Fernández-Concha J, Cansino JR, et al. Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial[J]. BMC Urol, 2020, 20(1): 65.
[14]
Rendina D, De Filippo G, D'Elia L, et al. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence[J]. J Nephrol, 2014, 27(4): 371-376.
[15]
Wong YV, Cook P, Somani BK. The association of metabolic syndrome and urolithiasis[J]. Int J Endocrinol, 2015, 2015: 570674.
[16]
Itoh Y, Yasui T, Okada A,et al. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis[J]. J Urol, 2005, 173(1): 271-275.
[17]
Hnow R, Gu K, Hesse A, et al. Oxalate content of green tea of different origin, quality, preparation and time of harvest[J]. Urological Research, 2010, 38(5): 377-381.
[18]
Nasir SJ. The mineralogy and chemistry of urinary stones from the united arab emirates[J]. Qatar Univ Sci, 1999, 18: 189-202.
[19]
Wiseman O, Ventimiglia E, Doizi S, et al. Effects of silicone hydrocoated double loop ureteral stent on symptoms and quality of life in patients undergoing flexible ureteroscopy for kidney stone: a randomized multicenter clinical study[J]. J Urol, 2020, 204(4): 769-777.
[20]
Lamb AD, Vowler SL, Johnston R, et al. Meta-analysis showing the beneficial effect of a-blockers on ureteric stent discomfort[J]. BJU Int, 2011, 108(11): 1894-1902.
[21]
Park SC, Jung SW, Lee JW, et al. The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms[J]. J Endourol, 2009, 23(11): 1913-1917.
[22]
Robert M, Boularan AM, El Sandid M, et al. Double-J ureteric stent encrustations: clinical study on crystal formation on polyurethane stents[J]. Urol Int, 1997, 58(2): 100-104.
[23]
Kawahara T, Ito H, Terao H, et al. Ureteral stent encrustation, incrustation, and coloringmorbidity related to indwelling times[J]. J Endourol, 2012, 26(2): 178182.
[24]
Tunney MM, Keane PF, Jones DS, et al. Comparative assessment of ureteral stent biomaterial encrustation[J]. Biomaterials, 1996, 17(15): 1541-1546.
[25]
Zhang Y, He J, Chen H, et al. A new hydrophilic biodegradable ureteral stent restrain encrustation both in vitro and in vivo[J]. J Biomater Appl, 2021, 35(6): 720-731.
[26]
Rouprêt M, Daudon M, Hupertan V, et al. Can ureteral stent encrustation analysis predict urinary stone composition?[J]. Urology, 2005, 66(2): 246-251.
[27]
章又云,李恭会. 输尿管支架管石痂与原发结石成分的对比及成因分析[J]. 中华医学杂志, 2020, 100(14): 1084-1086.
[28]
Zhang D, Li S, Zhang Z, et al. Urinary stone composition analysis and clinical characterization of 1520 patients in central China[J]. Sci Rep, 2021, 11(1): 6467.
[1] 李佳伟, 庞建智, 闫鹏宇, 卫阳兵, 杨晓峰. 术中输尿管识别技术研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 520-524.
[2] 方道成, 陈立新, 胡媛媛. 输尿管支架结壳的相关研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 402-405.
[3] 杨文刚, 赖义明, 黄浩, 黄海. 斜跨位上下联通置入Allium覆膜输尿管支架治疗输尿管狭窄的初步经验[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 340-345.
[4] 苏博兴, 肖博, 李建兴. 2024年美国泌尿外科学会年会结石领域手术治疗相关热点研究及解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 303-308.
[5] 俞国杰, 瓦热斯·先木西丁, 米尔扎提·麦麦提, 吴婷, 张洁祥. 复发性泌尿系结石成分变化及其影响因素分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 259-265.
[6] 方道成, 王勇, 胡媛媛. 泌尿系结石患者尿液菌谱及药敏特点分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 64-68.
[7] 徐哲, 罗杰, 吴强, 李忠, 王晓伟, 郑硕, 郝晓东, 王照. 腹主动脉钙化患者肾结石成分特点及危险因素分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 481-485.
[8] 周子健, 吴忠. CT在泌尿系结石诊疗中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 299-302.
[9] 胡月, 袁媛, 韩江英. 输尿管支架置入患者护理评估与干预研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 86-89.
[10] 马涛, 叶春伟, 李志鹏. 输尿管镜碎石术后留置输尿管支架的必要性探讨[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 463-467.
[11] 邓超华, 李炯明, 刘建和, 方克伟, 王光, 李沛, 段飞. 经皮肾镜联合输尿管镜治疗双J管长期滞留并发结石[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 335-338.
[12] 汤朝晖, 张建生, 陈洋. 光谱CT虚拟平扫在泌尿系结石CT尿路造影中的应用价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(03): 244-247.
[13] 徐涛, 唐鑫伟, 胡浩. 输尿管狭窄的内镜治疗:现状与未来[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(03): 177-181.
[14] 王欢, 张英慧, 张德伟, 金艳华, 辛雨, 谌卫, 郭志勇, 张艳宁, 关欣. 泌尿系结石相关梗阻性肾病及碎石术后急性肾损伤发生的危险因素分析[J/OL]. 中华肾病研究电子杂志, 2023, 12(06): 323-328.
[15] 张曦才, 曹先德. 经皮肾镜取石术治疗无积水肾结石中皮肾通道建立的应用研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(08): 911-915.
阅读次数
全文


摘要